ValiRx Plc (EAJF)
FSX
Real-time Data
06:00 AM
Day's Range
0.0005052 wk Range
0.00050Overview - EAJF - ValiRx Plc
Key Statistics
Valuation
Enterprise Value
-1.02M
P/E (Trailing)
‪-0.09‬
Price / Sales (TTM)
‪21.04‬
Price / Book
‪0.10‬
EV / EBITDA
‪0.55‬
Profitability
Profit Margin
‪-19.92%‬
Operating Margin
‪-2,832.24%‬
Return on Assets
‪-33.04%‬
Return on Equity
‪-72.52%‬
Ownership
Shares Outstanding
742.72M
Float
699.27M
Held by Insiders
‪8.95%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪-0.61‬
50-Day Avg
‪0.00050‬
200-Day Avg
‪0.00061‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - EAJF - ValiRx Plc
Peers - EAJF - ValiRx Plc
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- EAJFFSXValiRx Plc660.15KMarket Cap-200.00%52-week change-0.09P/E (Trailing)‪-19.92%‬Profit Margin
- ANLFSXAnalog Devices Inc.151.88BMarket Cap+35.24%52-week change43.41P/E (Trailing)‪29.78%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.72BMarket Cap+28.41%52-week change38.89P/E (Trailing)‪32.26%‬Profit Margin
- 1AEFSXargenx SE52.93BMarket Cap+23.73%52-week change38.15P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna Inc.50.90BMarket Cap+83.96%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.43.02BMarket Cap+35.18%52-week change143.35P/E (Trailing)‪30.74%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.64BMarket Cap+77.80%52-week change-29.52P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - EAJF - ValiRx Plc
About
ValiRx Plc is a biotechnology company specializing in the development of novel treatments for cancer and other diseases. The company primarily focuses on the translation of scientific discoveries into effective clinical therapies, playing a vital role in the intersection of molecular and cellular biology. ValiRx leads…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
